Alibhai Imran Nizamudin — SEC Form 4 filings

SEC reporting owner CIK 2064884. 4 Form 4 filings on record with FilingPulse; latest filed 2026-02-02.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2025-04-17 to 2026-02-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Tvardi Therapeutics, Inc. (TVRD)Chief Executive Officer, Director46

Form 4 filings — Alibhai Imran Nizamudin

FiledFormIssuerReported transactionsSource
2026-02-024Tvardi Therapeutics, Inc. (TVRD)Grant/award (A): 115,000 (derivative) @ $0EDGAR
2025-12-184Tvardi Therapeutics, Inc. (TVRD)Grant/award (A): 47,500 (derivative) @ $0EDGAR
2025-04-214Tvardi Therapeutics, Inc. (TVRD)Grant/award (A): 182,320 (derivative) @ $0EDGAR
2025-04-174Tvardi Therapeutics, Inc. (TVRD)Grant/award (A): 207,881 (derivative) · Grant/award (A): 2,011 (derivative) · Grant/award (A): 160,940 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2064884 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →